Oncotracker, Inc: OncoTracker Expands Multiple Myeloma Intellectual Property
OncoTracker has years of experience accurately measuring soluble BCMA in the blood of thousands of multiple myeloma patients.
Read full article »
CEO
James Kuo
OncoTracker is a biotechnology company that researches, develops and commercializes novel therapeutics for the treatment of cancer.
Read more